Home › Funds › Center for Wealth Management Advisory › JNJ

Center for Wealth Management Advisory position in JNJ

JOHNSON & JOHNSON · Health Care

Center for Wealth Management Advisory reported holding 10,457 shares of JNJ (JOHNSON & JOHNSON) in its Q2 2026 13F filing — a position valued at US$2.7M, representing 1.67% of its reported portfolio and ranking #10 among its reported holdings. Center for Wealth Management Advisory has disclosed JNJ holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)10.46K sh
Reported value held$2.66M
Portfolio Weight1.67%
First reportedQ4 2025
Last changeNew
Updated2026-10-09

How Center for Wealth Management Advisory's JNJ position evolved

Center for Wealth Management Advisory first disclosed a stake in JNJ in Q4 2025 at 10,876 shares (US$2.3M). The position peaked in Q2 2026 at 10,457 shares, worth US$2.7M. Across 3 filings, Center for Wealth Management Advisory increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 10,457 shares valued at US$2.7M.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 10.88K $2.25M New
Q1 2026 10.30K $2.52M Reduce
Q2 2026 10.46K $2.66M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →